| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |